Complement C3 deficiency prevent against the onset of streptozotocin-induced autoimmune diabetes involving expansion of regulatory T cells

Clinical Immunology

Volumn 140, Issue 3, 2011, Pages 236-243

  Gao, Xiaogang ^a   Liu, Huanhai ^a   Ding, Guoshan ^a   Wang, Zhengxin ^a   Fu, Hong ^a   Ni, Zhijia ^a   Ma, Jun ^a   Liu, Fang ^a   Fu, Zhiren ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune diabetes; Complement; Regulatory T cells; Streptozotocin; TGF

Indexed keywords

COMPLEMENT COMPONENT C3; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STREPTOZOCIN DIABETES; T CELL DEPLETION;

ANIMALS; COMPLEMENT C3; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 80051791847     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.02.004     Document Type: Article

References (30)

1. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
2. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144.
3. Volonakis J.E., Frank M.M. The Human Complement System in Health and Disease 1998, Dekker, New York.
4. Duncan R.C., Wijeyewickrema L.C., Pike R.N. The initiating proteases of the complement system: controlling the cleavage. Biochimie 2008, 90:387-395.
5. Flierl M.A., Rittirsch D., Chen A.J., Nadeau B.A., Day D.E., Sarma J.V., Huber-Lang M.S., Ward P.A. The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cellsfuring experimental sepsis. PLoS ONE 2008, 3:e2560.
6. Robbins R.A., Russ W.D., Rasmussen J.K., Clayton M.M. Activation of the complement system in the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1987, 135:651-658.
7. Linton S.M., Morgan B.P. Complement activation and inhibition in experimental models of arthritis. Mol. Immunol. 1999, 36:905-914.
8. Welch T.R. Complement in glomerulonephritis. Nat. Genet. 2002, 31:333-334.
9. Arumugam T.V., Shiels I.A., Woodruff T.M., Granger D.N., Taylor S.M. The role of the complement system in ischemia-reperfusion injury. Shock 2004, 21:401-409.
10. Tuzun E., Li J., Saini S.S., Yang H., Christadoss P. Targeting classical complement pathway to treat complement mediated autoimmune diseases. Adv. Exp. Med. Biol. 2008, 632:265-272.
11. Hawlisch H., Wills-Karp M., Karp C.L., Kohl J. The anaphylatoxins bridge innate and adaptive immune reponses in allergic asthma. Mol. Immunol. 2004, 41:123-131.
12. Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994, 343:271-275.
13. Li Q., Nacion K., Bu H., Lin F. The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am. J. Pathol. 2009, 175:661-667.
14. Lin M., Yin N., Murphy B., Medorf M.E., Segerer S., Heeger P.S., Schroppel B. Immune cell-derived C3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 2010, 59:2247-2252.
15. Liu J., Lin F., Strainic M.G., An F., Miller R.H., Altuntas C.Z., Heeger P.S., Tuohy V.K., Medorf M.E. IFN-γ and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production. J. Immunol. 2008, 180:5882-5889.
16. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
17. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
18. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
19. Peng Q., Li K., Anderson K., Farrar C.A., Lu B., Smith R.A., Sacks S.H., Zhou W. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3Ar interaction. Blood 2008, 111:2452-2461.
20. Weaver D.J., Reis E.S., Pandey M.K., Kohl G., Harris N., Gerard C., Kohl J. C5a receptor-deficient dendritic cells promote induction of Treg and Th17. Eur. J. Immunol. 2010, 40:710-721.
21. Lernmark A., Agardh C.D. Immunomodulation with human recombinant autoantigens. Trends Immunol. 2005, 26:608-612.
22. Vila J., Isaacs J.D., Anderson A.E. Regulatory T cells and autoimmunity. Curr. Opin. Hematol. 2009, 16:274-279.
23. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998, 188:287-296.
24. Belghith M., Bluestone J.A., Barriot S., Megret J., Bach J.F., Chatenoud L. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 2003, 9:1202-1208.
25. Wahl S.M., Allen J.B., Costa G.L., Wong H.L., Dasch J.R. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor β. J. Exp. Med. 1993, 177:225-230.
26. Burton O.T., Zaccone P., Phillips J.M., De La Pena H., Fehervari Z., Azuma M., Gibbs S., Stockinger B., Cooke A. Role of TGF-β and programmed cell death ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic mice. J. Immunol. 2010, 185:2754-2762.
27. Wahl S.M., Swisher J., McCartney-Francis N., Chen W. TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J. Leukoc. Biol. 2004, 76:15-24.
28. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
29. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004, 172:5149-5153.
30. Anderson M.S., Bluestone J.A. The NOD mouse; a model of immune dysregulation. Annu. Rev. Immunol. 2005, 23:447-485.